ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,10192
-0,05%
Bitcoin
66.863,92
-0,11%
Brent Oil
83,76
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. AnPac Bio Medical Science Company Ltd (ANPC)

  7. AnPac Bio Medical Science Company Ltd (ANPC) Notícias

ANPC

AnPac Bio Medical Science (ANPC)

AnPac Bio Medical Science Company Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ANPC
DataHoraFonteTítuloCódigoCompanhia
22/04/202409:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANPCAnPac Bio Medical Science Company Ltd
02/04/202410:01Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:ANPCAnPac Bio Medical Science Company Ltd
25/03/202417:02Edgar (US Regulatory)Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]NASDAQ:ANPCAnPac Bio Medical Science Company Ltd
15/06/202317:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ANPCAnPac Bio Medical Science Company Ltd
22/05/202312:28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ANPCAnPac Bio Medical Science Company Ltd
19/05/202313:55PR Newswire (US)Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES'NASDAQ:ANPCAnPac Bio Medical Science Company Ltd
16/05/202318:00PR Newswire (US)Fresh2 Files Annual Report on Form 20-F for Fiscal Year 2022NASDAQ:ANPCAnPac Bio Medical Science Company Ltd
16/05/202317:35Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ANPCAnPac Bio Medical Science Company Ltd
16/05/202317:15PR Newswire (US)Fresh2 Reports Fiscal Year 2022 Annual Financial ResultsNASDAQ:ANPCAnPac Bio Medical Science Company Ltd
16/05/202317:15PR Newswire (US)Fresh2 Reports First Quarter of Fiscal Year 2023 Financial ResultsNASDAQ:ANPCAnPac Bio Medical Science Company Ltd
06/04/202321:10GlobeNewswire Inc.Univest Securities, LLC Announces Closing of $3.0 Million Registered Direct Offering for its Client AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC)NASDAQ:ANPCAnPac Bio Medical Science Company Ltd
06/04/202320:15PR Newswire (US)AnPac Bio-Medical Science Announces Closing of $3.0 Million Registered Direct OfferingNASDAQ:ANPCAnPac Bio Medical Science Company Ltd
03/04/202310:00PR Newswire (US)AnPac Bio-Medical Science Enters into Asset Purchase Agreement with Easy Hundred Inc.NASDAQ:ANPCAnPac Bio Medical Science Company Ltd
31/03/202322:06GlobeNewswire Inc.AnPac Bio-Medical Science Announces Pricing of $3.0 Million Registered Direct OfferingNASDAQ:ANPCAnPac Bio Medical Science Company Ltd
23/03/202309:00PR Newswire (US)AnPac Bio-Medical Science Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting the Equity Rule on or before July 12, 2023NASDAQ:ANPCAnPac Bio Medical Science Company Ltd
07/03/202309:30PR Newswire (US)AnPac Bio Announces Receipt of the First Payment from a Malaysia Customer On a Signed US$1.5 Million Cancer Detection Equipment Purchase ContractNASDAQ:ANPCAnPac Bio Medical Science Company Ltd
06/03/202310:30PR Newswire (US)AnPac Bio-Medical Science Announces US$5 Million Private PlacementNASDAQ:ANPCAnPac Bio Medical Science Company Ltd
22/02/202309:30PR Newswire (US)AnPac Bio Announces Positive Results from its Multi-Year and Multi-Cancer Test Follow-Up StudyNASDAQ:ANPCAnPac Bio Medical Science Company Ltd
15/02/202310:00PR Newswire (US)AnPac Bio-Medical Science Acquires GISN (HK) LIMITED, a Technical Solution and Outsourcing Consulting Services ProviderNASDAQ:ANPCAnPac Bio Medical Science Company Ltd
13/02/202310:00PR Newswire (US)AnPac Bio-Medical Science Enters into Definitive Agreement to Make Another Acquisition to Significantly Expand Scope of Business in the U.S.NASDAQ:ANPCAnPac Bio Medical Science Company Ltd
09/02/202310:00PR Newswire (US)AnPac Bio-Medical Science Enters into Definitive Agreement to Acquire Fresh2 Ecommerce Inc, a B2B Asian Food E-commerce PlatformNASDAQ:ANPCAnPac Bio Medical Science Company Ltd
25/01/202310:30GlobeNewswire Inc.AnPac Bio-Medical Science Announces Signing of US$5.2 Million of Definitive Investment AgreementsNASDAQ:ANPCAnPac Bio Medical Science Company Ltd
20/01/202318:30GlobeNewswire Inc.AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request A HearingNASDAQ:ANPCAnPac Bio Medical Science Company Ltd
19/12/202218:15GlobeNewswire Inc.AnPac Bio Reports 48.8% Decrease in Net Loss in First Half of 2022NASDAQ:ANPCAnPac Bio Medical Science Company Ltd
05/12/202209:00GlobeNewswire Inc.AnPac Announces Strategic Initiative to Establish A Wholly-Owned Subsidiary for US Food MarketNASDAQ:ANPCAnPac Bio Medical Science Company Ltd
05/12/202209:00GlobeNewswire Inc.AnPac Announces the Plan of US$5,000,000 Private PlacementNASDAQ:ANPCAnPac Bio Medical Science Company Ltd
30/11/202209:00GlobeNewswire Inc.AnPac Announces Regaining Compliance with Nasdaq Listing RequirementNASDAQ:ANPCAnPac Bio Medical Science Company Ltd
10/11/202209:30GlobeNewswire Inc.AnPac Bio Announces Changes to the Board of DirectorsNASDAQ:ANPCAnPac Bio Medical Science Company Ltd
04/11/202208:30GlobeNewswire Inc.AnPac Bio Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting $1 Bid Price Compliance Rule On or Before Nov. 23, 2022NASDAQ:ANPCAnPac Bio Medical Science Company Ltd
24/10/202215:05Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)NASDAQ:ANPCAnPac Bio Medical Science Company Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:ANPC

Seu Histórico Recente

BOV
CXSE3R
Caixa Seguridade Partici... ON
BOV
PETRW30
PETRW30 Ex:25,84
BOV
BRGE5L
ALFA CONSORCIO PNA
EU
BRNL
Brunel International NV
AMEX
PIP
NASDAQ
LPTX
Leap Therapeutics
BMF
WINQ24
WINQ24 - Agosto 2024
BOV
CXSE3Q
Caixa Seguridade Partici... ON
LSE
0R7I
Roy Ceramics
BOV
CGEE3
Companhia Estadual De Ge... ON
NYSE
NTI
USOTC
SPDE
Speedus (CE)
AMEX
TAS
BOV
CEEB3
COELBA ON
BOV
BBASD5
BBASD5 Ex:27,25
AMEX
GHN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados